Covered recipient · General Payments record
YVETTE KIMBLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,131.01
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,333.98 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $377.19 | 3 |
| Novo Nordisk AS | $336.00 | 3 |
| ABBVIE INC. | $200.05 | 2 |
| Neurelis, Inc. | $124.94 | 1 |
| Otsuka America Pharmaceutical, Inc. | $124.01 | 1 |
| Amgen Inc. | $91.04 | 1 |
| Acerta Pharma LLC | $80.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $85.25 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107464077 | CMS |
| ABBVIE INC. | $114.80 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107464079 | CMS |
| Amgen Inc. | $91.04 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297636 | CMS |
| AstraZeneca Pharmaceuticals LP | $80.75 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104459584 | CMS |
| Gilead Sciences, Inc. | $130.08 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133686920 | CMS |
| Gilead Sciences, Inc. | $130.63 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133686922 | CMS |
| Gilead Sciences, Inc. | $116.48 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133686924 | CMS |
| Neurelis, Inc. | $124.94 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665951 | CMS |
| Novo Nordisk Inc | $120.90 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100357054 | CMS |
| Novo Nordisk Inc | $98.08 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100576394 | CMS |
| Novo Nordisk Inc | $117.02 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100310537 | CMS |
| Otsuka America Pharmaceutical, Inc. | $124.01 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119112407 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.